Niki BioSolutions, Inc. (NIKI) Free cash flow 2020–2025
Niki BioSolutions, Inc. (NIKI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.8MFY2025 · since FY2020: -$21.6M → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | -33.6% |
| FY2024 | -$1.4M | +82.5% |
| FY2023 | -$7.9M | +37.1% |
| FY2022 | -$12.5M | +19.4% |
| FY2021 | -$15.5M | +28.2% |
| FY2020 | -$21.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net incomeNIKI Net marginNIKI Gross profitNIKI Gross marginNIKI Operating incomeNIKI Operating marginNIKI Operating cash flowNIKI Capital expendituresNIKI Return on equityNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Total liabilitiesNIKI Shareholders’ equityNIKI overview →